M&T Bank
AXSM icon

M&T Bank’s Axsome Therapeutics AXSM Stock Holding History

M&T Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$701K Buy
2,862
+408
+17% +$88.5K ﹤0.01% 1062
2026
Q1 		$415K Sell
2,454
-106
-4% -$18.3K ﹤0.01% 1219
2025
Q4 		$467K Buy
2,560
+696
+37% +$97.2K ﹤0.01% 1166
2025
Q3 		$226K Buy
+1,864
New +$210K ﹤0.01% 1337

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

M&T Bank's AXSM Position: Q2 2026 in Review

M&T Bank increased its Axsome Therapeutics (AXSM) stake by 17% in Q2 2026, buying an estimated $88.5K and bringing the position to 2,862 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

M&T Bank first reported a position in AXSM in Q3 2025 and has held it in 4 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • M&T Bank held 2,862 shares of Axsome Therapeutics worth $701K as of Q2 2026.
  • M&T Bank bought 408 Axsome Therapeutics shares in Q2 2026, an estimated $88.5K.
  • Axsome Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1062 holding.
  • M&T Bank first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.